Avondale Partners Downgrades TrueBlue (TBI) to Underperform
Tweet
Share
E-mailGet Alerts TBI Hot Sheet
Price: $7.02 +0.86%
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 19 | New: 18
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 19 | New: 18
Join SI Premium – FREE
Avondale Partners downgraded TrueBlue (NYSE: TBI) from Market Outperform to Underperform with a price target of $15.00 (from $20.00).
For an analyst ratings summary and ratings history on TrueBlue click here. For more ratings news on TrueBlue click here.
Shares of TrueBlue closed at $20.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FTAI Infrastructure (FIP) PT Lowered to $12 at Compass Point
- Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR49 at BMO Capital
- Akzo Nobel NV (AKZA:NA) (AKZOY) PT Raised to EUR55 at Jefferies
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Avondale PartnersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
